295 related articles for article (PubMed ID: 5695705)
1. [On the therapy of muscular diseases].
Mittelbach F; Bodechtel G
Munch Med Wochenschr; 1968 Sep; 110(36):1988-93. PubMed ID: 5695705
[No Abstract] [Full Text] [Related]
2. Use of drugs in myopathies.
Grob D
Annu Rev Pharmacol Toxicol; 1976; 16():215-29. PubMed ID: 180877
[No Abstract] [Full Text] [Related]
3. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
Kunze K
Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
[No Abstract] [Full Text] [Related]
4. Treatment of myasthenia. II.
Br Med J; 1971 Apr; 2(5755):213-4. PubMed ID: 5575956
[No Abstract] [Full Text] [Related]
5. Diseases of the central nervous system. Myasthenia gravis.
Havard CW
Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
[No Abstract] [Full Text] [Related]
6. [Current treatment of myasthenia gravis].
de Assis JL
Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
[No Abstract] [Full Text] [Related]
7. [Drug therapy in myasthenia gravis].
Aarli JA
Tidsskr Nor Laegeforen; 1976 Dec; 96(34-36):1803-5. PubMed ID: 189451
[No Abstract] [Full Text] [Related]
8. [Therapy of peripheral oculomotor paralysis].
Huber A
Bibl Psychiatr Neurol; 1969; 139():296-312. PubMed ID: 4109458
[No Abstract] [Full Text] [Related]
9. Myasthenia gravis and glycopyrrolate.
Marcus E; Wayne F
S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
[No Abstract] [Full Text] [Related]
10. [Muscular diseases].
Refsum S
Tidsskr Nor Laegeforen; 1971 Apr; 91(11):838-40. PubMed ID: 5089806
[No Abstract] [Full Text] [Related]
11. [Therapy of myasthenia gravis in pregnancy].
Pezzoli G; Bonfadini Bossi E; Rella R
Minerva Ginecol; 1980; 32(1-2):21-6. PubMed ID: 6245392
[No Abstract] [Full Text] [Related]
12. Post-varicella myasthenia gravis.
Saha A; Batra P; Vilhekar KY; Chaturvedi P
Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
[TBL] [Abstract][Full Text] [Related]
13. [Immunodepressive agents in neurology].
Sabouraud O
Rev Prat; 1986 Jan; 36(5):229-36. PubMed ID: 2870559
[No Abstract] [Full Text] [Related]
14. [Treatment of myopathies and spinal muscular atrophies (author's transl)].
Jerusalem F
Schweiz Rundsch Med Prax; 1978 Jan; 67(4):118-22. PubMed ID: 341113
[No Abstract] [Full Text] [Related]
15. Teaching NeuroImages: reversible ectropion in myasthenia gravis.
Solé G; Perez F; Ferrer X
Neurology; 2009 Oct; 73(16):e83. PubMed ID: 19841376
[No Abstract] [Full Text] [Related]
16. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
Riggs JE
Clin Neuropharmacol; 1982; 5(3):277-92. PubMed ID: 6288236
[No Abstract] [Full Text] [Related]
17. Treatment of myasthenia--I.
Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
[No Abstract] [Full Text] [Related]
18. [Current therapy of myasthenia gravis. I. Specific symptomatic therapy].
Erbslöh F
Nervenarzt; 1972 Jul; 43(7):341-4. PubMed ID: 4627866
[No Abstract] [Full Text] [Related]
19. [Therapy of myopathies].
Esslen E
Bibl Psychiatr Neurol; 1969; 139():480-93. PubMed ID: 5406917
[No Abstract] [Full Text] [Related]
20. Dermatomyositis and myastenia gravis: An uncommon association with therapeutic implications.
Sangüesa Gómez C; Flores Robles BJ; Méndez Perles C; Barbadillo C; Godoy H; Andréu JL
Reumatol Clin; 2015; 11(4):244-6. PubMed ID: 25498320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
